Futures up on hopes of progress in trade war; Boeing shares slip

This post was originally published on this site


By Shreyashi Sanyal

(Reuters) – Wall Street looked set to start the week on an upbeat note on Monday, as investors hoped for progress in resolving the U.S.-China trade war, but a fall in Boeing’s shares kept a lid on early gains.

Chinese Vice Premier Liu He said on Saturday that Beijing would work with Washington to address core concerns, adding to optimism from President Donald Trump’s comments on Friday that he expected a trade deal to be signed by mid-November.

Microsoft Corp (O:) rose 0.8% in premarket trading after German business software group SAP (DE:) said it had signed a three-year cloud partnership with the company.

However, Boeing Co (N:) was set to extend a slide from the previous session as two brokerages downgraded the stock after leaked messages from a former test pilot showed he might have unintentionally misled regulators about the safety of the grounded 737 MAX jet.

Shares of the planemaker fell nearly 2%.

Wall Street has been steadily recovering after a rough start to the month on signs of progress in talks between the world’s two largest economies.

The benchmark S&P 500 () index ended Friday with its second weekly gain, while the Nasdaq () rose for three weeks in a row.

At 7:19 a.m. ET, were up 29 points, or 0.11%. S&P 500 e-minis were up 6.25 points, or 0.21% and were up 21 points, or 0.27%.

Investors are now gearing up for another batch of reports after a strong start to the third-quarter earnings season last week, with big technology companies including Microsoft Corp (O:) and Intel Corp (O:) set to report their earnings this week.

Analysts project S&P 500 earnings dropping 3.1%, compared with a year earlier, marking the first contraction since 2016, according to Refinitiv data.

But of the 73 companies that have reported results so far, nearly 84% have topped analysts’ estimates.

Oilfield services provider Halliburton Co (N:) dipped 0.4% after reporting a 32% slump in third-quarter profit, hit by a slowdown in shale drilling in North America, its biggest market.

Drug distributors Cardinal Health Inc (N:) fell 3% and McKesson Corp (N:) slipped 4.1%, ahead of a trial over the U.S. opioid epidemic after drug companies and local governments failed to reach a settlement on Friday.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Add Comment